Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

UKSHA’s infection prevention control guidance still applies to pharmacies

Despite the government’s announcement on lifting most Covid-19 related restrictions from next Thursday (January 27), people working in community pharmacies will be required to adhere to the UK Health Security Agency’s infection prevention control (IPC) guidance.

The ambit the guidance, which aims to protect everyone against the infection, also covers GP practices, dental practices and optometry practices, the Pharmaceutical Services Negotiating Committee said in an update.


The negotiators also urged community pharmacy teams to encourage patients to wear a face covering while vising pharmacy to keep staff and other patients safe.

Prime minister Boris Johnson announced on Wednesday (January 19) that Covid-19 restrictions re-imposed in England last month would be lifted by from next Thursday (January 27).

The government has decided to end the guidance on working from home, mandatory certification based on vaccines and tests along with the legal mandate to wear face masks.

Reacting to the prime minister’s announcement, Andrew Lane, chair of the National Pharmacy Association (NPA) said: “We continue to urge people to wear masks in pharmacies, in line with UK Health Security Agency guidance.”

Matthew Taylor chief executive of the NHS Confederation said: “While it is the job of the prime minister and the government to weigh up the balance of pros and cons for lifting restrictions, this is not the time for complacency about this virus.

“Covid-19 has not magically disappeared, and we are likely to have to learn to live alongside it for years to come. Lifting restrictions doesn’t mean a return to normality is inevitable.

"We need to be honest with the public that a decision to lift restrictions is a trade-off. We will have greater freedoms but the cost - at least in the short term - will be that more people are likely to get sick with Covid, and that the health service will continue to have to deal with the extra burdens that this creates.

He added: “As we move from a pandemic to an endemic, we know the virus will continue to circulate in the community so people should do all they can to mitigate the risk to themselves and others, testing themselves regularly, ventilating rooms frequently even in the winter months and wearing masks when in crowded places.

More For You

Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less
NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less